630 related articles for article (PubMed ID: 35313315)
1. COVID-19 Outbreaks in Nursing Homes Despite Full Vaccination with BNT162b2 of a Majority of Residents.
Lafuente-Lafuente C; Rainone A; Guérin O; Drunat O; Jeandel C; Hanon O; Belmin J;
Gerontology; 2022; 68(12):1384-1392. PubMed ID: 35313315
[TBL] [Abstract][Full Text] [Related]
2. Alpha Variant Coronavirus Outbreak in a Nursing Home Despite High Vaccination Coverage: Molecular, Epidemiological, and Immunological Studies.
Zürcher K; Abela IA; Stange M; Dupont C; Mugglin C; Egli A; Trkola A; Egger M; Fenner L
Clin Infect Dis; 2023 Aug; 77(4):537-546. PubMed ID: 35522980
[TBL] [Abstract][Full Text] [Related]
3. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data.
Haas EJ; Angulo FJ; McLaughlin JM; Anis E; Singer SR; Khan F; Brooks N; Smaja M; Mircus G; Pan K; Southern J; Swerdlow DL; Jodar L; Levy Y; Alroy-Preis S
Lancet; 2021 May; 397(10287):1819-1829. PubMed ID: 33964222
[TBL] [Abstract][Full Text] [Related]
4. Protective effects of prior third dose mRNA vaccination in rural nursing home residents during SARS-CoV-2 outbreaks.
Rhynold ES; Quan S; Orr PH; LaBine L; Singer A; St John PD
J Am Geriatr Soc; 2022 Nov; 70(11):3245-3249. PubMed ID: 35938635
[TBL] [Abstract][Full Text] [Related]
5. Receptor binding domain-IgG levels correlate with protection in residents facing SARS-CoV-2 B.1.1.7 outbreaks.
Blain H; Tuaillon E; Gamon L; Pisoni A; Miot S; Delpui V; Si-Mohamed N; Niel C; Rolland Y; Montes B; Groc S; Rafasse S; Dupuy AM; Gros N; Muriaux D; Picot MC; Bousquet J
Allergy; 2022 Jun; 77(6):1885-1894. PubMed ID: 34652831
[TBL] [Abstract][Full Text] [Related]
6. BNT162b2 vaccination reduced infections and transmission in a COVID-19 outbreak in a nursing home in Germany, 2021.
Meyer ED; Sandfort M; Bender J; Matysiak-Klose D; Dörre A; Bojara G; Beyrer K; Hellenbrand W
Influenza Other Respir Viruses; 2023 Jan; 17(1):e13051. PubMed ID: 36082799
[TBL] [Abstract][Full Text] [Related]
7. Infections, Hospitalizations, and Deaths Among US Nursing Home Residents With vs Without a SARS-CoV-2 Vaccine Booster.
McConeghy KW; Bardenheier B; Huang AW; White EM; Feifer RA; Blackman C; Santostefano CM; Lee Y; DeVone F; Halladay CW; Rudolph JL; Zullo AR; Mor V; Gravenstein S
JAMA Netw Open; 2022 Dec; 5(12):e2245417. PubMed ID: 36477482
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of Coronavirus Disease 2019 (COVID-19) Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Among Residents of US Nursing Homes Before and During the Delta Variant Predominance, December 2020-November 2021.
Hatfield KM; Baggs J; Wolford H; Fang M; Sattar AA; Montgomery KS; Jin S; Jernigan J; Pilishvili T
Clin Infect Dis; 2022 Oct; 75(Suppl 2):S147-S154. PubMed ID: 35856635
[TBL] [Abstract][Full Text] [Related]
9. Introduction of the BNT162b2 vaccine during a COVID-19 nursing home outbreak.
McEllistrem MC; Clancy CJ; Buehrle DJ; Lucas A; Pruskowski J; Handler SM; Decker BK
Am J Infect Control; 2021 Oct; 49(10):1237-1241. PubMed ID: 34363871
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 Delta Variant Breakthrough Infection and Onward Secondary Transmission in Household.
Yi S; Kim JM; Choe YJ; Hong S; Choi S; Ahn SB; Kim M; Park YJ
J Korean Med Sci; 2022 Jan; 37(1):e12. PubMed ID: 34981682
[TBL] [Abstract][Full Text] [Related]
11. Long-term effects of SARS-CoV-2 vaccination in the nursing home setting.
Rivasi G; Bulgaresi M; Bandinelli C; Balzi D; Tarantini F; Tognelli S; Lorini C; Buscemi P; Baggiani L; Landini G; Ungar A; Bonaccorsi G; Mossello E; Benvenuti E
J Am Geriatr Soc; 2022 May; 70(5):1336-1341. PubMed ID: 35347706
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of mRNA BNT162b2 COVID-19 vaccine against SARS-CoV-2 Delta variant among elderly residents from a long-term care facility, South of France, May 2021.
Sánchez Ruiz MA; Adonias G; Robaglia-Schlupp A; Rapilly F; Chabert M; Ramalli L; Reilhes O; Bruel C; Malfait P; Chaud P
Eur Rev Med Pharmacol Sci; 2022 Apr; 26(7):2586-2591. PubMed ID: 35442474
[TBL] [Abstract][Full Text] [Related]
13. BNT162b2 Messenger RNA Vaccination Did Not Prevent an Outbreak of Severe Acute Respiratory Syndrome Coronavirus 2 Variant 501Y.V2 in an Elderly Nursing Home but Reduced Transmission and Disease Severity.
Bailly B; Guilpain L; Bouiller K; Chirouze C; N'Debi M; Soulier A; Demontant V; Pawlotsky JM; Rodriguez C; Fourati S
Clin Infect Dis; 2022 Feb; 74(3):517-520. PubMed ID: 33993228
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 outbreak in an elderly care home: Very low vaccine effectiveness and late impact of booster vaccination campaign.
van Ewijk CE; Hazelhorst EI; Hahné SJM; Knol MJ
Vaccine; 2022 Nov; 40(46):6664-6669. PubMed ID: 36216647
[TBL] [Abstract][Full Text] [Related]
15. Declining Prevalence of SARS-CoV-2 Antibodies among Vaccinated Nursing Home Residents and Staff Six Months after the Primary BNT162b2 Vaccination Campaign in Belgium: A Prospective Cohort Study.
Meyers E; Deschepper E; Duysburgh E; De Rop L; De Burghgraeve T; Van Ngoc P; Digregorio M; Delogne S; Coen A; De Clercq N; Buret L; Coenen S; Sutter A; Scholtes B; Verbakel JY; Cools P; Heytens S
Viruses; 2022 Oct; 14(11):. PubMed ID: 36366456
[TBL] [Abstract][Full Text] [Related]
16. Poor Antibody Response to BioNTech/Pfizer Coronavirus Disease 2019 Vaccination in Severe Acute Respiratory Syndrome Coronavirus 2-Naive Residents of Nursing Homes.
Pannus P; Neven KY; De Craeye S; Heyndrickx L; Vande Kerckhove S; Georges D; Michiels J; Francotte A; Van Den Bulcke M; Zrein M; Van Gucht S; Schmickler MN; Verbrugghe M; Matagne A; Thomas I; Dierick K; Weiner JA; Ackerman ME; Goriely S; Goossens ME; Ariën KK; Desombere I; Marchant A
Clin Infect Dis; 2022 Aug; 75(1):e695-e704. PubMed ID: 34864935
[TBL] [Abstract][Full Text] [Related]
17. Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers.
Angel Y; Spitzer A; Henig O; Saiag E; Sprecher E; Padova H; Ben-Ami R
JAMA; 2021 Jun; 325(24):2457-2465. PubMed ID: 33956048
[TBL] [Abstract][Full Text] [Related]
18. Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) outbreaks in nursing homes involving residents who had completed a primary coronavirus disease 2019 (COVID-19) vaccine series-13 US jurisdictions, July-November 2021.
Wilson WW; Keaton AA; Ochoa LG; Hatfield KM; Gable P; Walblay KA; Teran RA; Shea M; Khan U; Stringer G; Colletti JG; Grogan EM; Calabrese C; Hennenfent A; Perlmutter R; Janiszewski KA; Kamal-Ahmed I; Strand K; Berns E; MacFarquhar J; Linder M; Tran DJ; Kopp P; Walker RM; Ess R; Read JS; Yingst C; Baggs J; Jernigan JA; Kallen A; Hunter JC;
Infect Control Hosp Epidemiol; 2023 Jun; 44(6):1005-1009. PubMed ID: 36645205
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection and severe COVID-19 in children aged 5-11 years in Italy: a retrospective analysis of January-April, 2022.
Sacco C; Del Manso M; Mateo-Urdiales A; Rota MC; Petrone D; Riccardo F; Bella A; Siddu A; Battilomo S; Proietti V; Popoli P; Menniti Ippolito F; Palamara AT; Brusaferro S; Rezza G; Pezzotti P; Fabiani M;
Lancet; 2022 Jul; 400(10346):97-103. PubMed ID: 35780801
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of SARS-CoV-2 antibodies among Belgian nursing home residents and staff during the primary COVID-19 vaccination campaign.
Meyers E; De Rop L; Deschepper E; Duysburgh E; De Burghgraeve T; Van Ngoc P; Digregorio M; Delogne S; Coen A; De Clercq N; Buret L; Coenen S; De Sutter A; Scholtes B; Verbakel JY; Cools P; Heytens S
Eur J Gen Pract; 2023 Dec; 29(2):2149732. PubMed ID: 36440533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
